(Q43582320)

24 November 2017

title

Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant (English)

1 reference

24 November 2017

3

1 reference

24 November 2017

6

1 reference

24 November 2017

7

1 reference

24 November 2017

8

1 reference

24 November 2017

9

1 reference

24 November 2017

E Crisci

1

0 references

author name string

H Almanza

series ordinal

2

1 reference

24 November 2017

L Córdoba

series ordinal

4

1 reference

24 November 2017

E Gómez-Casado

series ordinal

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

26 March 2009

1 reference

24 November 2017

1 reference

24 November 2017

volume

387

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

303-312

1 reference

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Towards a unique and transmissible vaccine against myxomatosis and rabbit haemorrhagic disease for rabbit populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

The coat protein of Rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Virus-like particles: flexible platforms for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Inter- and intragenus structural variations in caliciviruses and their functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Plant-derived vaccine protects target animals against a viral disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Assembly of feline calicivirus-like particle and its immunogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

A second vaccine revolution for the new epidemics of the 21st century

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Preparation of cell cultures and vaccinia virus stocks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus-based vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Vaccines that facilitate antigen entry into dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Expression and self-assembly in baculovirus of porcine enteric calicivirus capsids into virus-like particles and their use in an enzyme-linked immunosorbent assay for antibody detection in swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Immune responses to bovine norovirus-like particles with various adjuvants and analysis of protection in gnotobiotic calves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Cross-presentation, dendritic cells, tolerance and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

The coming of age of virus-like particle vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Expression and characterization of Sapporo-like human calicivirus capsid proteins in baculovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

A role for the transcription factor RelB in IFN-α production and in IFN-α-stimulated cross-priming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Virus-like particles-universal molecular toolboxes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Rabbit hemorrhagic disease virus: genome organization and polyprotein processing of a calicivirus studied after transient expression of cDNA constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Type I interferons produced by dendritic cells promote their phenotypic and functional activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Virus-like particles of calicivirus as epitope carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

A universal influenza A vaccine based on the extracellular domain of the M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Three-dimensional structure of calicivirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

X-ray crystallographic structure of the Norwalk virus capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Cytokines and immunity to viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

A new foreign policy: MHC class I molecules monitor the outside world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Exact prediction of a natural T cell epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Influence of flanking sequences on presentation efficiency of a CD8+ cytotoxic T-cell epitope delivered by parvovirus-like particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Exploiting viral properties for the rational design of modern vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Rabbit hemorrhagic disease virus: identification of a cleavage site in the viral polyprotein that is not processed by the known calicivirus protease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.02.045

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2009.02.045

1 reference

24 November 2017

1 reference